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Abstract
Mutations in mitochondrial DNA (mtDNA) have been linked to a variety of metabolic, neuro-
logical and muscular diseases which can present at any time throughout life. MtDNA is repli-
cated by DNA polymerase gamma (Pol γ), twinkle helicase and mitochondrial single-
stranded binding protein (mtSSB). The Pol γ holoenzyme is a heterotrimer consisting of the
p140 catalytic subunit and a p55 homodimeric accessory subunit encoded by the nuclear
genes POLG and POLG2, respectively. The accessory subunits enhance DNA binding and
promote processive DNA synthesis of the holoenzyme. Mutations in either POLG or POLG2
are linked to disease and adversely affect maintenance of the mitochondrial genome, result-
ing in depletion, deletions and/or point mutations in mtDNA. A homozygous mutation located
at Chr17: 62492543G>A in POLG2, resulting in R182W substitution in p55, was previously
identified to cause mtDNA depletion and fatal hepatic liver failure. Here we characterize this
homozygous R182W p55 mutation using in vivo cultured cell models and in vitro biochemi-
cal assessments. Compared to control fibroblasts, homozygous R182W p55 primary dermal
fibroblasts exhibit a two-fold slower doubling time, reduced mtDNA copy number and
reduced levels of POLG and POLG2 transcripts correlating with the reported disease state.
Expression of R182W p55 in HEK293 cells impairs oxidative-phosphorylation. Biochemi-
cally, R182W p55 displays DNA binding and association with p140 similar to WT p55.
R182W p55 mimics the ability of WT p55 to stimulate primer extension, support steady-
state nucleotide incorporation, and suppress the exonuclease function of Pol γ in vitro. How-
ever, R182W p55 has severe defects in protein stability as determined by differential scan-
ning fluorimetry and in stimulating function as determined by thermal inactivation. These
data demonstrate that the Chr17: 62492543G>A mutation in POLG2, R182W p55, severely
impairs stability of the accessory subunit and is the likely cause of the disease phenotype.
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Introduction
Mitochondria are cellular organelles in eukaryotic organisms responsible for producing ATP
via electron transport and oxidative phosphorylation. Human mitochondria have their own
genome comprised of a 16.5 kb circular DNA (mtDNA). Hundreds to thousands of copies of
mtDNA exist within a cell depending on cell type and growth stage [1, 2]. The regions within
mitochondria containing most of the mtDNA and associated proteins are referred to as nucle-
oids. These regions occur along the matrix side of the mitochondrial inner membrane. Super-
resolution microscopy has shown recently that mitochondrial nucleoids contain 1–3 copies of
mtDNA and that each cell can contain hundreds of nucleoids [3, 4]. MtDNA encodes 37
genes, including 13 components of the electron transport chain (ETC), 22 transfer RNA’s
(tRNA’s), and 2 ribosomal RNA’s (rRNA). Mutation, deletion, and depletion of mtDNA are
responsible for many mitochondrial disorders [5, 6]. Mitochondrial disorders range in age of
onset from early infancy to late adulthood and present with a variety of overlapping pheno-
types [7, 8]. Typically, early onset mitochondrial diseases result from mtDNA depletion,
whereas late onset diseases result from mtDNA deletions [9].
Replication of mtDNA is performed by a core collection of nuclear-encoded proteins
including: DNA polymerase γ (Pol γ), twinkle helicase and single-stranded DNA binding
protein (mtSSB) [10]. Pol γ is the only known replicative mtDNA polymerase and functions
as a heterotrimer comprised of one 140 kDa catalytic subunit (p140) and a 55 kDa homodi-
mer accessory subunit (p55), encoded by nuclear genes POLG and POLG2, respectively. P55
has been characterized as a DNA binding protein that enhances and regulates p140 [11–18].
P55 functions as a processivity factor [11] and is unique among eukaryotic processivity fac-
tors due to its similarity to prokaryotic aminoacyl-tRNA synthetases [12, 19]. The symmet-
ric p55 homodimer binds to p140 in an asymmetric manner, with each monomer playing a
unique role. The p140-proximal subunit is reported to strengthen the DNA interaction
while the distal subunit accelerates nucleotide incorporation [16, 17]. Although p55 is con-
served among higher order eukaryotes, only vertebrate p55 is known to dimerize [20]. The
affinity of p55 monomers to dimerize has been estimated at a Kd of 0.1 nM [21] and the
apo structures reveal an extensive dimerization interface of about 4000 square angstroms
[12, 19].
Mutations within the mtDNA replication machinery have been implicated in mitochondrial
disease. Over 300 mutations have been identified within the POLG gene which are listed in the
Human DNA Polymerase Gamma Mutation Database (https://tools.niehs.nih.gov/polg/). A
small collection of heterozygous POLG2 mutations has also been identified and analyzed both
biochemically and in vivo. These include P205R, R369G, G451E and L475DfsX2, which were
originally characterized as mutant homodimers [13, 22–24]. Recent work characterizing hetero-
dimers with one WT and one mutant copy of p55 implicate the G451E as a strong dominant
negative mutation [25]. POLG2-/- knockout mice are embryonic lethal at day 8–8.5 demonstrat-
ing the importance of POLG2 for survival, while heterozygous POLG2+/- mice have a normal
phenotype [26]. Null mutations of POLG2 in Drosophila melanogaster lead to lethality in early
pupal stage [27] and knockdown of POLG2 in porcine oocytes stops oocyte maturation [28].
Recently, we identified the first homozygous POLG2 mutation in a patient who presented
with fulminant hepatic failure at three months of age and subsequently died at 9 months [29].
Severe mtDNA depletion was found in liver and muscle tissue along with partial depletion in
blood lymphocytes. Whole exome sequencing identified a single homozygous point mutation
located at Chr17: 62492543G>A which results in the R182W substitution. Both parents were
found to be heterozygous for this mutation. To date neither parent has presented with mito-
chondrial disease. Structurally, this substitution is located at the dimerization domain base
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(Fig 1A & 1B). Mutation to a Trp causes loss of electrostatic interactions that may be important
for stabilizing p55’s structure [29]. We hypothesized this mutation affects p55 dimerization,
leading to loss of function. A publicly available phenotypic prediction algorithm, PolyPhen-2
[30], suggests that R182W is likely to ablate function (http://genetics.bwh.harvard.edu/pph2/).
Interestingly, this residue is conserved among vertebrates with homodimeric p55 subunits, but
not conserved among invertebrates, where only monomeric p55 has been observed [29].
To better understand the effects of R182W substitution in p55, we assessed growth rates,
mtDNA copy number, and levels of select transcripts in patient dermal fibroblasts. We also
studied the bioenergetics of HEK293 cells expressing R182W p55. Finally, we purified and
characterized R182W p55 using a collection of biochemical assays, including comparative
assessments of intrinsic affinity to dsDNA, stimulation of p140 polymerase and exonuclease
steady state kinetics, enhancement of p140 processivity, physical association of p140 and p55,
physical thermostability, and thermostable stimulation of p140.
Materials and methods
POLG2 cloning
The R182W mutation was generated in the NHis-POLG2 and pJ603-NGFP- POLG2 [25] plas-
mids using the QuikChange site-directed mutagenesis kit (Stratagene) with the following
mutagenic primers: Forward (5’—CT TCT GGG AAA CTA TGG GAG AAC CTT CTT
CAC– 3’) and Reverse (5’—GTG AAG AAG GTT CTC CCA TAG TTT CCC AGA AG–
3’). Successful mutagenesis was confirmed by DNA sequencing the POLG2 insert. The under-
lined nucleotides are changed by site-directed mutagenesis.
Fibroblast cell culture
The research published here was approved by the IRB Office of Columbia University Medical
Center (AAAB5754). With verbal informed consent from the parents, skin biopsies were
obtained from the patient and were grown in 6-well plates using DMEM supplemented with
15% fetal bovine serum (FBS), 1% MEM vitamin solution and penicillin-streptomycin. With
informed consent, skin biopsies were obtained from patients and were grown in 6-well plates
using DMEM supplemented with 15% fetal bovine serum (FBS), 1% MEM vitamin solution
and penicillin-streptomycin. Once they reached confluency, fibroblast cultures were expanded
using 10% FBS DMEM in 10cm dishes. Neonatal dermal foreskin fibroblasts were purchased
from ATCC (Catalog # PCS-201-010). Cells were cultured in either glucose or galactose con-
taining DMEM. Glucose media consisted of low glucose DMEM (Catalog # 12320–032) supple-
mented with 100 U/mL penicillin, 100 μg/mL streptomycin, 0.25 μg/mL Gibco amphotericin B,
0.1 mM glycine, 0.1 mM L-alanine, 0.1 mM L-asparagine, 0.1 mM L-aspartic acid, 0.1 mM L-
glutamic acid, 0.1 mM L-proline, 0.1 mM L-serine and 10% FBS. Galactose media consisted of
DMEM without glucose (Catalog # 11966–025) supplemented with 10 mM HEPES, 100 U/mL
penicillin, 100 μg/mL streptomycin, 0.25 μg/mL Gibco amphotericin B, 0.1 mM glycine, 0.1
mM L-alanine, 0.1 mM L-asparagine, 0.1 mM L-aspartic acid, 0.1 mM L-glutamic acid, 0.1 mM
L-proline, 0.1 mM L-serine, 2 mM L-glutamine, 10 mM galactose, 1 mM sodium pyruvate and
10% FBS. Cells were grown at 37˚C in a humidified atmosphere with 5% CO2 in air. Cells were
routinely passaged by washing with PBS (pH 7.4), incubating with 0.25% trypsin, 1 mM EDTA
for 2 min and then neutralized with media. Cells were next plated at 1:5 and 1:10 dilutions to
maintain cells in the replicative growth phase. Vials of frozen cells were prepared in freezing
medium containing 40% glucose DMEM, 50% FBS, 10% DMSO and stored in the gas-phase of
a nitrogen freezer.
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Fibroblast growth rates
Growth curves of control and patient fibroblasts were performed in both glucose DMEM and
galactose DMEM. Cells were passaged at least twice in the desired media before seeding for the
growth curve. Control and patient fibroblasts were seeded in T-25 tissue culture flasks at
250,000 cells/flask at passage 7. Cells were grown at 37˚C in a humidified atmosphere with 5%
CO2 in air for 8 days. Three flasks were counted each day. To count the cells, they were washed
with PBS (pH 7.4) followed by incubation in 1 mL of 0.25% Trypsin, 1 mM EDTA for 2 min
and then neutralized with 1mL of the appropriate DMEM growth media. Cells were thor-
oughly resuspended, then counted in triplicate using a TC20TM Automated Cell Counter
(Bio-Rad). Total cell number was plotted versus time and the doubling times were calculated
via Td = T×ln(2)/ln(CF−CI) where T is the time between the two cell counts, CF is the final cell
count and CI is the initial cell count. The final and initial cell counts are based on the log phase
of the growth curve which was determined to be between days 1 and 3.
mtDNA copy number determination
1 x 107 fibroblasts were harvested and total DNA isolated using the Qiagen AllPrep DNA/
RNA/Protein mini kit following the manufacturer’s protocol. DNA was quantified by Qubit
Fluorimetric quantitation (Thermofisher Scientific) using the dsDNA assay kit. RPPH1 was
used as the control and both ND1 and ND4 regions were amplified to quantify mtDNA copy
number. The target sequence for each gene was placed into the pCR2.1 vector for absolute
quantification. 10 μL Real Time PCR reactions containing 5 μL 2x TaqMan Universal PCR
master mix no AmpErase UNG (Applied Biosystems), 0.5 μL 20X TaqMan Primer–Probe set
(RPPH1 cat #: Hs03297761_s1, ND1 cat #: Hs02596073_s1, ND4 cat #: P14331348, Applied
Biosystems), and 0.5 ng/μL genomic DNA were setup in a 384-well plate. Real time PCR
amplification was performed using a QuantStudio 7 Real-Time PCR instrument (Applied Bio-
systems) with the cycling parameters being 95˚C for 10 min, 95˚C 15 sec, 60˚C 1 min. The last
two steps were performed for 40 cycles. Each of the three pCR2.1 vectors (RPPH1, ND1 and
ND4) were used to create a standard curve with 102, 103, 104, 105, 106 and 107 copies/μL. Stan-
dard curves were repeated in triplicate for each gene on the plate. The DNA copy numbers
were plotted against Ct values and linear regression was used to generate correlation coeffi-
cients. Copy number (C) for each gene was determined and then mtDNA copy number was
calculated via C = M/H where M is the mtDNA genes (ND1 or ND4) and H is the nuclear gene
(RPPH1). Each sample was assayed five times on a single plate and experiments performed in
triplicate.
POLG and POLG2 transcript level determination
1 X 107 fibroblasts were harvested and total RNA isolated using the Qiagen AllPrep DNA/
RNA/Protein mini kit following the manufacturer’s protocol. RNA was quantified by Nano-
drop quantitation (Thermofisher Scientific). Complementary DNA (cDNA) was generated
from 0.5 μg of RNA using the High-Capacity cDNA Reverse Transcription Kit (Thermofisher
Scientific) following the manufacturer’s protocol. 10 μL Real Time PCR reactions containing
5 μL 2X TaqMan Universal PCR master mix no AmpErase UNG (Applied Biosystems), 0.5 μL
20X TaqMan Primer–Probe set (ACTB cat #: Hs1060665_g1, POLG cat #: Hs00160298_m1,
Fig 1. Location of the R182W amino acid substitution on the human apo p55 crystal structure. (A) Overview of the
human apo p55 dimer structure. One monomer has been colored blue while the other monomer is colored green.
Highlighted in red spheres is R182. (B) A 90o rotation of the structure. PDB: 1G5H [12].
https://doi.org/10.1371/journal.pone.0203198.g001
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POLG2 cat #: Hs00945167_m1, Applied Biosystems), and 0.5 μL 1:2 diluted cDNA was setup
in a 384-well plate. Real time PCR amplification was performed using a QuantStudio 7 Real-
Time PCR instrument (Applied Biosystems) with the cycling parameters at 95˚C for 10 min,
95˚C 15 sec, 60˚C 1 min. The last two steps were performed for 40 cycles. To calculate expres-
sion levels and fold change, the following equations were used: ΔCt = CtGI-CtActin, ΔΔCt =
ΔCtP- ΔCtC, FC = 2
-ΔΔCt where CtGI is the average Ct value of either POLG or POLG2, CtActin
is the average Ct value for Actin, ΔCtP are the patient fibroblast values, ΔCtC are the control
fibroblast values, and FC is fold change. Each sample was run five times on a single plate and
experiments performed in triplicate.
HEK293 cell culture and transfection
HEK293 cells (ATCC #CRL-1573) were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) (Life Technologies) without glucose (Catalog # 11966–025) and supplemented
with 10 mM galactose, 6 mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 100
U/mL penicillin, 100 μg/mL streptomycin, and 10% FBS. Cells were grown at 37˚C in a
humidified atmosphere with 10% CO2 in air. Cells were routinely passaged by washing
with PBS (pH 7.4), incubating with 0.25% trypsin, 1 mM EDTA (Life Technologies) for 2
min and then neutralized with media. Cells were next plated at 1:10 and 1:20 dilutions to
maintain cells in the replicative growth phase. Transfection was performed using the
Lonza NucleofectorTM 2b with the corresponding kit (AmaxaTM cell line kit V) according
to the manufacturers protocol. Cells were transfected with the previously described
pJ603-NGFP-POLG2 plasmid with and without the R182W mutation. Cells were trans-
fected using the Lonza NucleofectorTM 2b and then grown in the presence of 800 μg/mL
G418 for selection. After 4–5 days, selection was maintained with 50 μg/mL G418. Vials of
frozen cells were prepared in freezing medium containing 40% growth DMEM, 50% FBS,
10% DMSO and stored in the gas-phase of a nitrogen freezer.
Cellular bioenergetics
Cellular bioenergetics were determined using the Seahorse Biosciences XF24 extracellular flux
analyzer as previously described [25] with the following changes. Cells were cultured for 1–2
months in galactose media. HEK293 plates were seeded at 50,000 cells/well for untransfected
and wild type p55 HEK293 cells and 70,000 cells/well for R182W p55 HEK293 cells and grown
for two days at 37˚C in a humidified atmosphere with 10% CO2 in air before assaying. Plates
were checked for even seeding and 90–95% confluency. Data was normalized to cells seeded
for analysis.
P55 and p140 expression and purification
Wild-type (WT) and R182W p55 without the mitochondrial targeting sequence were
expressed in BL21(DE3) E. coli as previously described [31] with one change. The nickel col-
umn elution buffer used to purify R182W p55 was modified to include 100 mM NaCl. All
other buffers remained the same, ensuring that WT and R182W p55 are in the same buffer at
the end of the purification. The exonuclease-deficient (Exo-) p140, herein referred to as WT
p140, was overproduced in Spodoptera frugiperda (Sf9) insect cells and purified as previously
described [31]. WT and R182W p55 proteins were assessed by SEC-MALS using an AKTA
FPLC system (GE Healthcare) coupled to the miniDawn TREOS and Optilab rEX detectors
(Wyatt Technology).
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Protein concentration determination
Bovine serum albumin (BSA) standards ranging from 0.5–7 ug along with the protein to be
quantitated were run on 4–12% SDS-PAGE gels (Invitrogen) at 180 V for 60 min, then stained
with Coomassie blue. Gels were imaged using a SYNGENE G:Box gel doc system and bands
were quantitated with ImageJ64 [32]. The BSA standard areas were plotted against ug’s and
linear regression used to generate correlation coefficients. The concentration of protein was
then estimated against the BSA curve. BSA curves and the protein estimated were always run
on the same gel.
DNA binding electrophoretic mobility shift assay (EMSA)
For the apparent disassociation constants between DNA and WT p55 or R182W p55, the Kd
(DNA) was determined by DNA Binding EMSA in triplicate as previously described [22].
P140- p55 binding affinity
Holoenzymes were preassembled on ice in enzyme dilution buffer (EDB), composed of 50
mM Tris-HCl pH 7.5, 10% glycerol, 1 mM EDTA, 1 mM 2-ME, 100 mM KCl, and 0.005% NP-
40, with a constant 2.5 nM p140 concentration and varying concentrations (0, 0.5, 1.0, 1.5, 2.0,
2.5, 3.0, 4.0, 7.5, 10.0, 15.0, 20.0, 25.0 nM) for WT and R182W p55. 50 μL reactions containing
25 mM HEPES-KOH (pH 7.5), 2.5 mM 2-ME, 0.5 mM MnCl2, 200 μg/mL heat-treated BSA,
16 μCi/mL [α-32P] dTTP, 50 μg/mL poly(rA)•oligo(dT)12-18, 220 mM NaCl, varying concen-
trations of dTTP (0, 0.5, 1, 1.5, 2, 2.5, 3, 5, 10, 15, 20, 25 μM) and 5 μL of holoenzyme were
incubated at 37˚C for 9 min. Reactions were stopped by the addition of 1 mg/mL BSA in 0.1 M
NaPPi (0.2 mL) and cold 10% TCA (1 mL). The mixture was filtered through Whatman GF/C
filters, washed with 1N HCl, rinsed with 100% ethanol then dried. TCA-insoluble reactivity
was determined by liquid scintillation counting. Maximal polymerase activity for WT and
R182W p55 was set at 100% and apparent Kd(p55) values were derived by nonlinear regression
analysis of DNA polymerase activity at each concentration of p55 dimer, as described [33].
Steady-state kinetics
DNA polymerase activity on poly(rA)•oligo(dT)12-18 using preassembled holoenzyme
containing either WT or R182W p55 was determined as follows: 50 μL reactions contain-
ing 25 mM HEPES-KOH (pH 7.5), 2.5 mM 2-ME, 0.5 mM MnCl2, 200 μg/mL heat-treated
BSA, 16 μCi/mL [α-32P] dTTP, 50 μg/mL poly(rA)•oligo(dT)12-18, 220 mM NaCl, varying
concentrations of dTTP (0, 0.5, 1, 1.5, 2, 2.5, 3, 5, 10, 15, 20, 25 μM) and a fixed concentra-
tion of holoenzyme (1 nM p140 + 2 nM p55) were incubated at 37˚C for 0, 3, 6, 8 and 10
min. Reactions were stopped by the addition of 1 mg/mL BSA in 0.1 M NaPPi (0.2 mL)
and cold 10% TCA (1 mL). The samples were then filtered through Whatman GF/C filters,
washed with 1 N HCl, rinsed with 100% ethanol and dried before TCA-insoluble radioac-
tivity was determined by liquid scintillation counting. Steady-state kinetic values were
determined as previously described [11].
Exonuclease inhibition
Exonuclease activity was determined as previously described [34]. The final holoenzyme con-
centrations were: 0.3 nM p140 + 0.6 nM WT p55 and 0.4 nM p140 + 0.8 nM R182W p55.
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DNA processivity
Processivity of DNA synthesis was assessed as previously described [11] at 0 mM or 150 mM
NaCl, without the pre-incubation step or the DNA trap. Samples were run on 12% denaturing
PAGE gels.
Differential scanning fluorimetry (DSF)
WT and R182W p55 were diluted to 1 mg/mL in EDB. SYPRO Orange (Molecular Probes)
was diluted to 1X from a 40X stock in H2O. In a 96 well plate 20 μL of protein was mixed with
2.5 μL of SYPRO Orange. Using an ABI Prism 7900 Sequence Detection System (Applied Bio-
sciences) the samples were heated from 25˚C to 95˚C at a ramp rate of 4% with detection set to
the ROX reporter. The peak of the first derivative of the thermal melting curve defines the
melting temperature (Tm) for each protein. Data was analyzed using DMAN [35] and
MATLAB’s ThermoQ application (MathWorks).
Thermostability activity assay
WT and R182W p55 were diluted to 2 nM in EDB on ice and aliquoted into 10 μL samples.
WT p55 was pre-incubated at 75˚C for 0, 1.0, 3.0, 5.0, 7.0, 9.0, 12.0, 15.0, 25.0, 30.0, 45.0, 55.0,
65.0, 75.0, 90.0, 105.0, 120.0, 135.0, 150.0, 165.0, and 180.0 min while R182W p55 was pre-
incubated at 75˚C for 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0, 7.5, 10.0, 15.0, and 20.0
min. Each time point was placed on ice until the entire series was completed. Addition of 1
nM p140 while still on ice permitted assembly of holoenzymes. Reactions (50 μL) containing
25 mM HEPES-KOH (pH 7,5), 2.5 mM 2-ME, 0.5 mM MnCl2, 200 μg/mL heat-treated BSA,
220 mM NaCl, 300 μM dTTP, 16 μCi/mL [α-32P]-dTTP, 50 μg/mL poly(rA)•oligo(dT)12-18
primer-template and 5 μL heat-treated holoenzyme were incubated at 37˚C for 10 min. Reac-
tions were terminated and processed as described above. Activity observed for reactions with-
out heat treatment was set to 100%, and remaining activity was plotted against time of 75˚C
pre-incubation. Data were fit to an equation for exponential decay (Nt = Noe
-λt), which permit-
ted calculation of half-lives for inactivating p55 function (t1/2 = ln2/λ).
Results
Patient fibroblasts show delayed growth rates
To begin to understand the effects of the mutation at Chr17: 62492543G>A in POLG2
(R182W p55) on cellular health and metabolism, growth rates of patient dermal fibroblasts
were assessed in media with glucose or galactose. Requiring cultured cells to utilize galactose
as a sole carbon source obligates the cell to rely on oxidative phosphorylation rather than gly-
colysis for energy production providing a simple test for severe respiratory chain defects [36–
39]. When we switched the patient dermal fibroblasts to media containing galactose as the sole
carbon source, we observed significant cell killing of the patient fibroblasts. Cells were seeded
at 250,000 cells/T-25 flask at passage 7 and grown for 8 days with daily cell counting. Control
fibroblasts had a doubling time of 22.7 hours in glucose while patient fibroblasts grew signifi-
cantly slower with a doubling time of 56 hours in glucose (Fig 2A). Thus, the patient fibroblasts
grew more than half as slow as the control fibroblast in glucose. In galactose, control fibroblasts
had a doubling time of 24.5 hours while patient fibroblasts had a doubling time of 45.1 hours,
suggesting patient fibroblasts were able to grow better in galactose than glucose. Although
growth on galactose obligates mitochondrial respiration, the process of ensuring the fibroblasts
have switched to aerobic respiration may be applying selective pressure and agrees with the
observation of significant cell killing initially. Thus, only cells capable of surviving in those
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conditions grew and we likely artificially selected for healthier cells, making the galactose result
uninformative.
Patient fibroblasts have reduced mtDNA copy number
Since POLG2 is essential for mtDNA replication, loss of function mutations in POLG2 may
cause a failure of mtDNA replication. The reduced growth rate for patient fibroblasts led us to
determine mtDNA copy number to help establish whether R182W p55 is affecting mtDNA rep-
lication. Also, we had previously observed that the patient had reduced mtDNA copy number
in liver and muscle (25 and 19% of wild type, respectively) [29]. MtDNA copy number was
determined using absolute quantitative real time PCR. ND1 and ND4 amplification levels
(mtDNA) were normalized to nuclear RPPH1 levels to determine relative mtDNA copy num-
ber, and standard curves were used to calculate absolute mtDNA copy numbers. R182W p55
patient fibroblasts showed a significant decrease in mtDNA copy number with ND1 being 61%
of WT and ND4 being 64% of WT (p 0.05, N = 3, as determined by Student’s T-test) (Fig 2B).
Patient fibroblasts exhibit reduced p140 and p55 mRNA transcripts
Reduced mtDNA copy number could indicate either an inability of R182W p55 to stimulate
processive DNA synthesis and/or a reduction in the level of p55 expressed within the cell. To
help understand p55 function in the patient fibroblasts, we determined mRNA transcript levels
of both p140 and p55 by quantitative real-time PCR. Transcript levels for both p140 and p55
were significantly reduced in glucose (20% and 40% of control cells, respectively, p 0.01,
Fig 2. Patient dermal fibroblasts grow more slowly than control fibroblasts, have reduced mtDNA copy number
and reduced POLG/POLG2 transcript levels. (A) 8-day growth curves comparing control (black lines) and patient
(red lines) dermal fibroblasts grown in glucose. Every point on the curves is the average of three independent growths.
(B) MtDNA copy number was determined by quantitative PCR of the mitochondrial genes ND1 and ND4 and
normalized to the nuclear gene RPPH1, as described in Materials and methods. MtDNA copy number for control
fibroblasts (black circles–ND1/black triangles-ND4) or patient dermal fibroblasts (red circles-ND1/red triangles-ND4)
are shown. Standard curves of plasmids containing the amplified regions of interest allowed for absolute copy number
to be determined by real time PCR. Experiments were done in triplicate, and N = 5 for each data point. (C) Transcript
levels for POLG and POLG2 in patient fibroblasts were determined by quantitative PCR and normalized to ACTB as
described in Materials and methods. WT p55 (black circles–POLG/black triangles–POLG2) R182W p55 (Red circles–
POLG/red triangles–POLG2). Experiments were done in triplicate, and N = 5 for each data point.
https://doi.org/10.1371/journal.pone.0203198.g002
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N = 3, as determined by Student’s T-test) (Fig 2C). This indicates that transcription of R182W
p55 as well as p140 is reduced by the R182W mutation. The reduction of p140 and p55 tran-
scripts may be due to coregulation of these genes [40] or, more likely, due to suppression of
mitochondrial function in these patient fibroblasts when grown in glucose [39, 41]).
HEK293 cells expressing R182W POLG2 have impaired respiratory
capacity
The patient fibroblasts showed an inability to produce mtDNA, presumably due to the R182W
p55 mutation. However, these cells may have other unidentified mutations within either the
nuclear or mitochondrial DNA. To confirm the observations in the patient fibroblast were
caused by the R182W POLG2 mutation we episomally expressed either WT or R182W p55 in
HEK293 cells. HEK293 cells were transfected with plasmids expressing WT p55 or R182W
p55, and analysis of transcripts indicated a 5-fold overexpression of WT p55 compared to
endogenous p55 in untransfected cells, and expression of R182W p55 was equivalent to endog-
enous p55 in untransfected cells. We have previously shown that overexpression of WT p55
does not alter bioenergetics in HEK293 cells [25]. We did not observe a difference in mtDNA
copy number for R182W p55 or WT p55 HEK293 cells. We then sought to assess mitochon-
drial function using the Seahorse XF24 extracellular flux analyzer. The Seahorse XF24 extracel-
lular flux analyzer utilizes a 24-well cell culture plate that analyzes pH and oxygen
consumption of the cells to determine how well OX-PHOS is functioning. Inhibitors of oxida-
tive phosphorylation are sequentially added that inhibit ATP synthase (oligomycin), uncouple
Complexes I-IV from ATP synthase (2,4-dinitrophenol; 2,4-DNP), and then impede Com-
plexes I/III (rotenone/antimycin A). The efficiency of OX-PHOS is determined by monitoring
the oxygen consumption rate (OCR) during the addition of these compounds (Fig 3A).
Fig 3. Seahorse Flux Analyzer bioenergetics analysis of transfected HEK293 cells illustrates significant reduction
in respiration. (A) Representative graph of the oxygen consumption rate (OCR). ATP-linked oxygen consumption
and oxygen consumption associated with proton leakage can be differentiated by inhibiting ATP synthase with
oligomycin. Uncoupling electron transport and ATP synthase with 2,4-dinitrophenol (2,4-DNP) reveals the maximum
rate of oxygen consumption. The reserve respiratory capacity is the difference between maximal and basal respiration
rates. Complete inhibition of respiration using a combination of rotenone/antimycin A determines non-mitochondrial
oxygen consumption. The average basal OCR (B), maximal OCR (C), reserve respiratory capacity (D), proton leakage
(E) and ATP coupled production (F) for untransfected HEK293 (gray bars), WT POLG2 HEK293 (black bars) and
R182W POLG2 HEK293 (red bars) cells are shown. Values are averages ± SEM, N = 3 per group, normalized to cells
seeded.  p 0.05 versus the WT POLG2 transfected HEK293 cells as determined by Students t-test.
https://doi.org/10.1371/journal.pone.0203198.g003
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Despite equivalent levels of expression and mtDNA copy number, HEK293 cells expressing
R182W POLG2 clearly show defective OX-PHOS with statistically significant decreases for
basal respiration, maximal respiration, reserve capacity and ATP coupled production (
p 0.05 as determined by Students t-test, Fig 3B–3F).
Recombinant expression and purification of R182W p55
The analysis of HEK293 cells expressing R182W p55 indicated that the R182W mutation can
cause a defect in mitochondrial respiration. To better understand how the R182W p55 amino
acid substitution affects biochemical function, the mutation was generated by site-directed
mutagenesis, the recombinant protein was overproduced in E. coli and purified to homogene-
ity using the established protocol [11] with a single modification. The WT p55 is normally
eluted from Ni-NTA with no additional salt added, but under these conditions, the R182W
p55 precipitated during the elution. To ensure that the R182W p55 protein remained in solu-
tion the nickel elution buffer had to be adjusted to include 100 mM NaCl. This change can be
made during WT p55 purification without affecting its function. The overall yield was 4-fold
less than WT for equivalent starting material, which is sometimes indicative of structural/sta-
bility issues. Interestingly, analytical size exclusion chromatography indicated an apparent
native molecular weight of 86 kDa for R182W p55, whereas WT p55 eluted as expected at 110
kDa. Otherwise, behavior throughout the purification protocol was similar to WT p55. To
investigate whether the apparent native molecular weight was due to a shape change or an
equilibrium between monomer and dimer, we performed size exclusion chromatography
multi-angle light scattering (SEC-MALS). SEC-MALS data indicated that both R182W p55
and WT p55 exist as a single species (polydispersity of 1.000), suggesting a change in shape/
conformation for the R182W p55 protein.
R182W p55 DNA binding is similar to WT p55
P55 binds double strand DNA (dsDNA) independently of p140 [11], and dimerization of p55
is essential for dsDNA binding [42]. R182 is located at the base of the dimerization domain of
p55 (Fig 1A & 1B). R182W amino acid substitution predicts a loss of electrostatic interactions
between the monomers that could affect the structure of p55 and possibly alter dimerization
[29]. Accordingly, we assessed DNA binding by R182W p55 as a functional screen for defects
in dimerization. Various concentrations of WT and R182W p55 were incubated with a radio-
actively labelled 47-nucleotide double-stranded DNA oligomer as previously described [42].
Bound and unbound forms were resolved by electrophoretic mobility shift assay (EMSA), and
apparent disassociation constants for WT and R182W p55 were shown to be indistinguishable
(Table 1). This analysis suggests no defect in DNA binding by R182W p55.
Physical association of Pol γ is similar for R182W & WT p55
Known functions for p55 require association with dsDNA as well as association with the p140
catalytic subunit. Clinically identified mutations in POLG2 have been shown to disrupt associ-
ation of p55 and p140 [13, 22, 23]. We utilized a standard DNA synthesis assay with the homo-
polymeric primer-template substrate poly(rA)•oligo(dT)12-18 to assess the DNA polymerase
activity of Pol γ holoenzyme under conditions of saturating dTTP and a restrictive salt concen-
tration. At 220 mM NaCl, the DNA polymerase activity of p140 is insignificant without proper
association with p55. Accordingly, p140 activity was assessed at varied and increasing concen-
trations of p55, and the formation of active holoenzyme is a measure of physical association of
p140 and p55 subunits. The inter-subunit dissociation constant, Kd(p140) was calculated from a
reciprocal plot of nucleotide incorporation as a function of p55 concentration. WT and
Instability of the human DNA polymerase gamma accessory subunit in disease
PLOS ONE | https://doi.org/10.1371/journal.pone.0203198 August 29, 2018 11 / 20
R182W p55 were shown to bind p140 with similarly high affinities (0.35nM for the WT and
0.11nM for the R182W p55) (Table 1). While these numbers are statistically significant and
suggest a slight increase in binding affinity for R182W p55, the biological significance for this
modest tighter binding is unknown.
Effects on steady-state polymerase kinetics by p55
At physiological salt concentration, it has been shown that p140 requires p55 to function [11,
43]. Steady-state kinetic parameters were determined for p140 in the presence of p55 in a stan-
dard DNA synthesis assay using the homopolymeric primer-template substrate poly(rA)•oligo
(dT)12-18 with varying dTTP concentrations. Rates of dTMP incorporation over time were
used to calculate apparent Km(dTTP) and kcat values with the Michaelis-Menten steady-state
kinetic model (Table 1). No differences in the ability of R182W and WT p55 to modulate
kinetic parameters were identified.
P140’s exonuclease activity is influenced less by R182W p55 as compared to
WT p55
P140 possesses a 3’-to-5’ exonuclease activity, which has an excision rate (kexo) of 26.6 ± 0.8
min-1 in the absence of p55 (Table 1 which is similar to previously published values [34]. It
has previously been shown that p55 inhibits p140’s exonuclease activity by promoting pro-
cessive DNA synthesis [15]. Here we examined the effect of WT and R182W p55 on p140’s
exonuclease activity. Exonuclease activity was determined as previously reported [34] with
the modification that p140 was preincubated with p55 in a 2:1 ratio. Final enzyme concen-
trations were determined experimentally to be within the linear range for this exonuclease
assay and the steady state rate constant for excision of 3’-termini (kexo) was determined by
plotting loss of substrate versus time over 5 minutes. In the presence of WT p55, p140’s kexo
was 8.6 ± 2.3 min-1 while in the presence of R182W p55, p140’s kexo was 14.0 ± 1.2 min-1
(Table 1). This indicates that p55 impairs the exonuclease activity of p140 and that R182W
p55 does not impair activity as dramatically as WT p55, suggesting a mild defect in
association.
Table 1. Biochemical characterization of p55.
WT p55 R182W p55
DNA binding
Kd(DNA) (nM) 89.6 ± 18.6 84.2 ± 22.3
p140-p55 binding affinity
Kd(p140) (nM) 0.35 ± 0.04 0.11 ± 0.01
Steady-state kinetics
Km (μM) 1.19 ± 0.1 1.08 ± 0.04
kcat (min-1) 29.40 ± 0.91 34.65 ± 1.44
kcat/Km (μM•min)-1 27.64 ± 2.08 32.26 ± 1.39
Modulation of p140-exonuclease activity by p55
Rate (nt/min) 8.6 ± 2.3 14.0 ± 1.2
Table 1: DNA binding affinity, p140-p55 binding affinity, steady-state kinetics and exonuclease activity were
determined as described in Materials and methods. Values are averages ± SEM, N 3.
The p140-p55 binding affinity assay was performed at 220 mM NaCl.
The exonuclease activity of p140 in the absence of p55 was 26.6 ± 0.8.
https://doi.org/10.1371/journal.pone.0203198.t001
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Primer extension by p140 is similarly enhanced by R182W p55
The p55 accessory subunit stimulates salt tolerant DNA synthesis by Pol γ and also enhances
processive DNA synthesis by p140. On a primed M13 ssDNA primer-template, inclusion of
p55 increases p140’s processivity from 50–100 nucleotides to several thousand nucleotides
[11]. To compare further the effects of WT and R182W p55 on DNA synthesis by p140, we
evaluated processivity of DNA synthesis in the presence and absence of each p55 form at both
0 mM and 150 mM NaCl concentrations using a gel-based primer extension assay that permits
multiple DNA-binding events. R182W p55 enhances primer extension in a manner similar to
WT p55 (Fig 4, compare lanes 3 and 5 or 7 and 10), indicating that R182W p55 functions to
stimulate primer extension by p140 in a manner similar to WT p55.
Thermostability of R182W p55 is significantly reduced
The purification procedure for R182W p55 required addition of 100 mM NaCl to the nickel
column elution buffer to keep the protein in solution (see Materials and methods). This obser-
vation along with the SEC-MALS data suggested an altered stability for R182W-substituted
p55. To assess protein stability, we utilized differential scanning fluorimetry to determine the
melting temperatures for purified WT p55 and R182W p55. The fluorescent SYPRO Orange
dye was mixed with each protein separately, and fluorescence of SYPRO Orange was moni-
tored as the temperature was incrementally increased from 25˚C to 95˚C. As the protein
unfolds, more hydrophobic residues become available to interact with SYPRO Orange causing
an increase in fluorescence (Fig 5A). WT p55 exhibited a Tm of 82.7 ± 0.3˚C while R182W p55
had a Tm of 68.0 ± 0.3˚C (Fig 5A). This substantial decrease in melting temperature suggests a
significant reduction in protein stability for R182W p55.
Reduced thermostability of R182W p55 significantly impacts the ability to
stimulate p140
With a reduced melting temperature, it became of interest to determine if exposure to
increased temperatures would result in an inability to stimulate p140 in the standard DNA
synthesis assay using the homopolymeric primer-template substrate poly(rA)•oligo(dT)12-18.
In this assay, both WT and R182W p55 were heat inactivated at 75˚C for varying lengths of
time (WT up to 180 minutes, R182W up to 20 minutes). Pol γ holoenzymes were assembled in
vitro with p140 and samples of each treated p55, and holoenzyme activity was evaluated by
standard DNA synthesis assay. The half-life of WT p55 was determined to be 70.4 ± 4.4 min
while R182W p55 was determined to be 1.0 ± 0.1 min (Fig 5B). This 70-fold reduction in the
ability to stimulate p140 after heat treatment further indicates structural instability of R182W
p55.
Discussion
POLG2 has been shown to be essential for life through a collection of studies that have
revealed: (i) Homozygous knockout (POLG2-/-) mice die in utero at embryonic day E8.0–8.5,
while heterozygous mice (POLG2+/-) are haplosufficient and develop normally [26]. (ii) Null
mutations in Drosophila melanogaster POLG2 cause lethality in the early pupal stage [27] and
(iii) oocyte maturation is affected in a porcine POLG2 knockdown model [28]. Until recently,
the clinically identified mutations in POLG2 were all heterozygous mutations [13, 22–24]. The
Chr17: 62492543G>A POLG2 mutation (R182W p55) was the first homozygous POLG2 muta-
tion identified, and the affected infant presented with liver failure at 3 months of age and sub-
sequently died at 9 months [29]. We wanted to understand the effect of the R182W amino acid
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Fig 4. Stimulation of Pol γ processive DNA synthesis is similar for WT p55 and R182W p55. Primer extension
reactions were performed and analyzed by denaturing PAGE as described in Materials and methods. Samples with or
without p55 were assessed at 0 mM NaCl or at 150 mM NaCl, as indicated. Lanes 1 and 6 exclude enzyme. Lanes 2, 4, 8
and 9 exclude p55. Lanes 3 and 7 include WT p55 while lanes 5 and 10 include R182W p55. Lanes 1–5 have 0 mM
NaCl while lanes 6–10 have 150 mM NaCl. The gel is representative of three independent experiments.
https://doi.org/10.1371/journal.pone.0203198.g004
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substitution on p55 function to validate the cause of the mtDNA depletion and understand the
disease pathogenesis.
Ex vivo studies
As an initial screen, we assessed the growth rates of patient dermal fibroblasts grown in either
glucose or galactose media to understand whether the mutation at Chr17: 62492543G>A in
POLG2 (R182W p55) is detrimental to mitochondrial function. As expected, growth curves
identified a growth defect for the patient fibroblasts. The doubling time was about twice as
long as control cells. When we switched the fibroblasts to the galactose-based media significant
cell killing was observed. Growth in galactose as the sole sugar source forces cells to produce
energy via the OX-PHOS pathway thus ensuring we are examining mitochondrial energy pro-
duction [36–38]. A subset of cells did survive, suggesting we ultimately selected for cells
Fig 5. R182W p55 has a stability defect that disrupts p140 stimulation. (A) Differential Scanning Fluorimetry with
SYPRO Orange dye. Protein was incubated with SYPRO Orange and warmed from 25˚C to 95˚C, as described in
Materials and methods. Fluorescence of SYPRO Orange increases as more hydrophobic patches become available for
binding, thereby reporting the degree of protein denaturation. R182W p55 has a lower melting temperature than WT
p55. (B) Thermostability of WT p55 and R182W p55 was assessed in a p140 stimulation assay, as described in
Materials and methods. WT p55 and R182W p55 were incubated at 75˚C for increasing amounts of time, and
holoenzymes were assembled and tested for the ability to incorporate dTTP. The half-life for thermal denaturation of
R182W p55 is 70-fold shorter than the half-life for WT p55.
https://doi.org/10.1371/journal.pone.0203198.g005
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capable of surviving in the galactose media. Although dermal fibroblasts are easily obtained
from patients; Robinson et al [39] noted approximately 50% of dermal fibroblasts from
patients with mitochondrial disease are nonviable in galactose. Additionally, it has been
reported that human epidermal cells are functionally anaerobic and thus do not require mito-
chondria for their viability [41]. Taken together, this suggests that fibroblast cells are not
always the most appropriate cell type in which to study mitochondrial respiration. The most
severely affected tissues in this patient were liver and muscle, however primary cells were not
available for this study.
P55 functions to enhance p140’s replication of mtDNA, thus we determined the mtDNA
copy number and mRNA transcript levels for POLG and POLG2. Both mtDNA copy number
and transcript levels were significantly reduced when grown in glucose.
The patient fibroblasts grown in glucose confirm that mitochondrial dysfunction is present
and suggest R182W p55 may be the cause. However, unidentified mutations may also be pres-
ent within the fibroblasts. To isolate the effect R182W p55 has on cellular function, we
expressed R182W p55 in HEK293 cells as previously reported [25]. These cells were grown in
galactose media and cellular respiration was studied using the Seahorse XF24 extracellular flux
analyzer. The R182W cells had significant defects in OX-PHOS function with the exception of
proton leakage implying that R182W p55 may be detrimental to mitochondrial respiration. To
determine the specific effect of R182W p55 substitution we purified and characterized R182W
p55.
Biochemical studies
The known biochemical functions of WT and R182W p55 were assessed in vitro. Double-
stranded DNA binding affinity, p140 binding affinity, steady state stimulation of p140 DNA
polymerase activity and stimulation of processive DNA synthesis by Pol γ were all similar for
R182W p55 and WT p55. We found a reduction in the inhibition of exonuclease activity by
R182W p55 as compared to WT p55. Together these results indicate that R182W p55 functions
in a manner similar to WT p55 in vitro. However, during purification it was noted that the
conditions had to be modified to obtain soluble protein. This suggested potential instability of
the protein.
The R182W amino acid substitution lies at the base of the dimerization domain of p55 (Fig
1A & 1B), and this mutation disrupts a collection of electrostatic interactions potentially alter-
ing the structure of p55 homodimers [29]. Analysis by analytical sizing column indicates that
R182W p55 has an apparent molecular weight of 86 kDa rather than WT p55’s 110 kDa, sug-
gesting either a change in structure or an equilibrium between monomer and dimer exists.
SEC- MALS data indicated that R182W p55 exists as a single species so an equilibrium is not
present thus leaving a change in structure as the explanation. During purification of R182W
p55, buffer modification was necessary to ensure R182W p55 would remain soluble. Taken
together, these data suggest R182W p55 may have stability issues. To confirm this idea, we
found that R182W p55 melts 14.7˚C lower than WT p55 as determined by DSF. We further
tested whether this difference in melting temperature would lead to an inability to stimulate
p140. WT or R182W p55 were exposed to 75˚C for a collection of time points, added to p140
and then assayed for polymerase activity under conditions requiring functional interaction of
p55 with p140. This assay identified a large difference between WT and R182W p55, with the
half-life for R182W p55 being 70-fold shorter than WT p55. Collectively, these results indicate
that R182W p55 has a severe stability issue that results in loss of function. Recent studies indi-
cate that oxidative phosphorylation derived respiration may result in an increased internal
temperature of mitochondria of around 50˚C rather than 37˚C. One interesting possibility is
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that this higher temperature would exacerbate the stability defect of R182W p55 [44] and
potentially lead to the presentation of disease in the clinic. Alternatively, unstable proteins pro-
voke a variety of responses within living cells, including lowering of mRNA transcript levels,
rapid degradation of expressed protein, blockages in the endoplasmic reticulum or the forma-
tion of amyloids [45, 46]. The patient dermal fibroblasts exhibit a dramatic reduction in tran-
script levels for both p140 and p55, supporting the idea that R182W p55 is unstable. Recently,
lowered p55 protein levels as a result of a heterozygous splice site mutation in the POLG2 gene
was found responsible for adult onset syndromic sensory neuropathy, ataxia and parkinsonism
and mtDNA deletions [47].
Concluding remarks
We have characterized the first clinically identified homozygous mutation of human POLG2,
R182W. Our studies indicate that when R182W p55 is folded properly and in solution, it func-
tions similarly to WT p55. However, R182W p55 has a significant stability defect that dramati-
cally impairs its ability to function. This stability defect is likely caused by the loss of
electrostatic interactions normally afforded by the Arg side chain. Ex vivo studies indicate that
patient dermal fibroblasts have a growth defect, reduced mtDNA copy number and lower tran-
script levels for both p140 and p55. HEK293 cells expressing R182W p55 have across the board
reduced OX-PHOS capabilities. Taken together the results strongly suggest defects in the
R182W p55 protein are responsible for mtDNA depletion in the patient and the subsequent
onset of symptoms [29].
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